August 3, 2021 Clinical Research/Diagn. PR/Corporate

Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India

Aug 3, 2021 SAN DIEGO, Aug. 3, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) has donated $1 million in sequencing capabilities to the Molecular Diagnostic Reference Laboratory at Kasturba Hospital, in the Municipal Corporate of Greater Mumbai, to help expand SARS-CoV-2 sequencing capabilities in the region and support the broader genomic surveillance effort across India. Kasturba Hospital was... Read more

August 2, 2021 Clinical Research/Diagn. Liq. Handling & Robotics M&A, Partnerships

Tecan successfully completes the acquisition of Paramit

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Männedorf, Switzerland, August 2 2021 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has successfully completed the acquisition of US-based Paramit Corporation and its affiliates (“Paramit”) for a total purchase consideration of USD 1.0 billion (CHF 920 million). On June 23, 2021, Tecan... Read more

July 28, 2021 Bio/Pharma/CRO Chemicals, Reagents & Kits Clinical Research/Diagn. Lab Top-10 Product Launch

PerkinElmer Expands KRAS Oncology Drug Discovery Assays with New Ready-to-Use AlphaLISA Kits

Mailing addressesCorrespondence should be mailed to:ComputershareP.O. Box 505000Louisville, KY 40233 Overnight correspondence should be sent to:Computershare462 South 4th Street, Suite 1600Louisville, KY 40202 Shareholder website www.computershare.com/investorShareholder online inquirieswww-us.computershare.com/investor/Contact Read more

July 19, 2021 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 Life Science Tools

Thermo Fisher Scientific Expands Hematology Oncology NGS Portfolio

Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers CARLSBAD, Calif., July 19, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T-cells and B-cells, which play a key role in the immune... Read more

July 9, 2021 Clinical Research/Diagn.

GE Healthcare to Offer End-To-End Deep Learning Solutions with Spectronic Medical to Improve Accuracy for Radiation Oncology Treatment

Chicago/Helsingborg, Sweden July 9, 2021:  GE Healthcare announces the integration of Spectronic Medical AB AI-based software[1] for more precise cancer treatment planning. This AI solution, in combination with GE Healthcare’s industry leading AIR Recon DL technology, enables MR-only based radiotherapy planning for better soft tissue differentiation than traditional CT, so clinicians can better direct radiotherapy.... Read more

July 9, 2021 Clinical Research/Diagn. PAI Top-10

WHO guidelines now include Roche’s diagnostic tests in expanded effort to eliminate tuberculosis by providing patients greater access to timely diagnosis

Tuberculosis is a disease of poverty, and economic distress with 1.4 million deaths annually1 and the growing challenge of drug resistance is adding to the global health crisis WHO guidelines support the expansion of tuberculosis diagnostics in resource-limited countries, enabling patients to receive timely diagnosis leading to proper treatment, which benefits their recovery and slows... Read more

July 7, 2021 Clinical Research/Diagn.

GE Healthcare’s Industry-First Contrast-Guided Biopsy Solution, Serena Bright, Installed in Five Major Hospitals in the United States

Serena Bright™ sets new standards for breast cancer detection and biopsy technology CHICAGO, IL July 7, 2021:  GE Healthcare today announced the installation of Serena Bright™ in five hospitals and radiology centers around the United States. Serena Bright™ is the industry’s first contrast-guided biopsy solution, helping empower clinicians and patients in their fight against breast... Read more

July 7, 2021 Clinical Research/Diagn. Lab Top-10

Thermo Fisher Scientific and UC Davis Launch Center of Excellence in Clinical Metabolomics

Thermo Fisher Scientific and UC Davis Launch Center of Excellence in Clinical Metabolomics Center will develop new technologies and reproducible analytical techniques to support rapid, cost-effective clinical research into applications for metabolomics in precision medicine SAN JOSE, Calif. and DAVIS, Calif., July 7, 2021 /PRNewswire/ — Thermo Fisher Scientific, (NYSE: TMO) the world leader in serving... Read more

July 7, 2021 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Announces Collaboration with Ortho Clinical Diagnostics

Exclusive agreement to provide Thermo Scientific MAS Quality Controls for VITROS Analyzers FREMONT, Calif., July 7, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Ortho Clinical Diagnostics to promote and distribute Thermo Scientific MAS Quality Controls and LabLink xL Quality Assurance Software for use with Ortho Clinical Diagnostics VITROS... Read more

June 25, 2021 Clinical Research/Diagn. PAI Top-10

Teen Scientist Creates Novel Diagnostic Tool for Inflammatory Bowel Disease (IBD)

From May 16 to May 21, 2021, nearly 2,000 young scientists, engineers, entrepreneurs and inventors convened virtually for a week of connecting with their peers and global STEM leaders, events, and $5 million in awards and prizes. The finalists, selected from nearly 400 affiliate fairs in 64 countries, regions and territories, have all completed exemplary... Read more